Free tool
FAERS Monitor: Otrexup
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204824 or its brand name (Otrexup, Methotrexate). Reports on generic versions are filed under their own applications.
Reports
417,645
Serious
315,340
76% of reports
Hospitalization
119,785
Death reported
34,414
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective75,997
- rheumatoid arthritis38,640
- arthralgia36,856
- pain36,004
- off label use35,326
- fatigue29,671
- nausea24,467
- joint swelling22,658
- headache21,327
- rash20,369
- condition aggravated20,265
- drug intolerance20,024
- diarrhoea18,682
- pain in extremity18,139
- pyrexia17,490
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5,129 |
| 2005 | 5,083 |
| 2006 | 4,969 |
| 2007 | 7,782 |
| 2008 | 8,995 |
| 2009 | 9,160 |
| 2010 | 9,678 |
| 2011 | 10,610 |
| 2012 | 14,953 |
| 2013 | 16,975 |
| 2014 | 16,967 |
| 2015 | 20,365 |
| 2016 | 21,909 |
| 2017 | 22,749 |
| 2018 | 32,398 |
| 2019 | 32,440 |
| 2020 | 39,843 |
| 2021 | 26,547 |
| 2022 | 29,258 |
| 2023 | 26,872 |
| 2024 | 23,124 |
| 2025 | 20,104 |
| 2026 | 11,726 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,636,514 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| rheumatoid arthritisSignal | 38,640 | 25.5 | 25.2 | 602,394 |
| drug intoleranceSignal | 20,024 | 12.9 | 12.7 | 175,152 |
| joint swellingSignal | 22,658 | 11.4 | 11.2 | 175,733 |
| arthralgiaSignal | 36,856 | 4.8 | 4.8 | 103,112 |
| condition aggravatedSignal | 20,265 | 3.5 | 3.5 | 34,709 |
| pain in extremitySignal | 18,139 | 3.2 | 3.2 | 26,703 |
| painSignal | 36,004 | 3.1 | 3.0 | 48,829 |
| drug ineffectiveSignal | 75,997 | 3.0 | 3.0 | 103,261 |
| pyrexiaSignal | 17,490 | 2.6 | 2.6 | 17,023 |
| rashSignal | 20,369 | 2.4 | 2.4 | 16,513 |
| off label useSignal | 35,326 | 2.1 | 2.1 | 19,701 |
| fatigue | 29,671 | 2.0 | 1.9 | 13,840 |
| headache | 21,327 | 1.7 | 1.7 | 6,656 |
| nausea | 24,467 | 1.6 | 1.6 | 5,166 |
| diarrhoea | 18,682 | 1.5 | 1.5 | 2,824 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.